NCT06355804Active, not recruiting
Lifestyle Physical Activity Intervention for Persons Newly Diagnosed With Multiple Sclerosis
Source: ClinicalTrials.gov · Last updated 17 Sept 2025
Brief summary (registry, in English)
The overall objective of the current study is to determine the efficacy of a 16-week remotely delivered lifestyle behavioral intervention compared with a control condition (i.e., waitlist control) in persons newly diagnosed with MS (disease duration ≤ 2 years). Specific Aim 1: To evaluate the changes in self-report and device-measured physical activity after the 16-week remotely delivered physical activity behavior change intervention compared with a control condition (i.e., waitlist control) in persons who have diagnosed with MS within the past two years. The investigators hypothesize that the 16-week behavior change intervention will yield greater improvements in physical activity levels than the control condition immediately after the intervention. Specific Aim 2: To investigate the efficacy of the 16-week, remotely delivered physical activity behavior change intervention compared with the control condition for improvements in fatigue, depression, anxiety, and QoL in persons newly diagnosed with MS. The investigators hypothesize that there will be beneficial effects on the symptoms and QoL outcomes immediately after the physical activity intervention compared with minimal changes in the control condition.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 52 (actual)
- First submitted
- 27 Mar 2024
- Start date
- 29 Apr 2024
- Primary completion date
- 1 Aug 2026
- Lead sponsor
- University of Illinois Chicago
- Diseases
- Multiple sclerosis
- NCT number
- NCT06355804
What you commit to
- Study type: Interventional
- Participants enrolled: 52
- From 29 Apr 2024 to the primary completion date, 1 Aug 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- pregnant
- have elevated risk for undertaking strenuous or maximal exercise based on two or more affirmatives on the Physical Activity Readiness Questionnaire (PAR-Q)
Who the study is looking for
- aged 18 years or older
- self-reported diagnosis of MS by a neurologist within the past 2 years
- relapse-free for the past 30 days
- ability to speak and read English as primary language
- internet and e-mail access, and willingness to complete the testing and questionnaires
- ambulatory without an assistive device (e.g., cane)
- insufficiently active (Godin Leisure-Time Exercise Questionnaire (GLTEQ) \< 14)
- visual ability and literacy to read newsletter with font size 14 points
- on a disease-modifying therapy.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Illinois Chicago Coordinator of this site? Confirm its status | Chicago | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.